PATHOLOGY ARTS INC NPI 1396842472

NPI Details

PATHOLOGY ARTS INC is a clinical medical laboratory in Corona, CA. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. PATHOLOGY ARTS INC NPI is 1396842472. The provider is registered as an organization entity type.

The provider's business location address is:

549 QUEENSLAND CIR STE 101
CORONA, CA
ZIP 92879-397
Phone: (951) 270-0605
Fax: (951) 270-0675

The provider's authorized official is Curtis Lee Tague .
The authorized official title is Ceo and has the following contact phone number (951) 270-0605.

The CLIA number assigned to this NPI record is 05D1000595 - independent with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)

The enumeration date for this NPI number is 9/20/2006 and was last updated on 3/27/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.